Browse
Explore conditions, clinical trials, and the organisations running them.
7477 conditions with clinical trials.
- Malignant glioma 3588 trials
- Brain cancer 3583 trials
- Prostate neoplasm 3521 trials
- Esophageal cancer 3515 trials
- Estrogen-receptor positive breast cancer 3480 trials
- Kidney cancer 3458 trials
- Bone neoplasm 3444 trials
- Head and neck neoplasm 3439 trials
- Skin cancer 3432 trials
- Rectal cancer 3430 trials
- Cervical cancer 3425 trials
- Biliary tract cancer 3401 trials
- Renal carcinoma 3401 trials
- Malignant epithelial tumor of ovary 3385 trials
- Estrogen-receptor negative breast cancer 3382 trials
- Progesterone-receptor negative breast cancer 3380 trials
- Triple-negative breast carcinoma 3380 trials
- Neuroendocrine carcinoma 3375 trials
- Ovarian carcinoma 3373 trials
- High grade astrocytic tumor 3372 trials
- Progesterone-receptor positive breast cancer 3369 trials
- Uterine carcinoma 3360 trials
- Pharynx cancer 3359 trials
- Transitional cell carcinoma 3359 trials
- Colorectal adenocarcinoma 3356 trials
- Renal cell carcinoma 3355 trials
- Urothelial carcinoma 3354 trials
- Glioblastoma 3352 trials
- Endometrial cancer 3351 trials
- Urinary bladder cancer 3348 trials
- Metastatic prostate carcinoma 3346 trials
- Hormone receptor-positive breast cancer 3344 trials
- Urinary bladder carcinoma 3341 trials
- Childhood acute lymphoblastic leukemia 3332 trials
- Pancreatic ductal adenocarcinoma 3332 trials
- Gastric carcinoma 3327 trials
- Soft tissue sarcoma 3315 trials
- B-cell childhood acute lymphoblastic leukemia 3309 trials
- Central nervous system neoplasm 3298 trials
- Malignant soft tissue neoplasm 3293 trials
- Bile duct cancer 3292 trials
- Childhood leukemia 3291 trials
- Metastatic malignant neoplasm in the brain 3290 trials
- Pediatric lymphoma 3290 trials
- Bile duct carcinoma 3287 trials
- Carcinoma of esophagus 3285 trials
- Invasive carcinoma 3285 trials
- Primary mediastinal large B-cell lymphoma 3276 trials
- Gastric adenocarcinoma 3271 trials
- Gastroesophageal junction adenocarcinoma 3271 trials